• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MetLife Announces First Quarter 2021 Preferred Stock Dividend Actions

    2/16/21 4:15:00 PM ET
    $PRE
    $MET
    $PRA
    Blank Checks
    Finance
    Life Insurance
    Finance
    Get the next $PRE alert in real time by email

    NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends:

    • Quarterly dividend of $9.47875000 per share on the company’s 5.250% fixed-to-floating rate non-cumulative preferred stock, Series C, with a liquidation preference of $1,000 per share.
    • Semi-annual dividend of $29.375 per share on the company’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share.
    • Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE: MET PRE).
    • Quarterly dividend of $296.875 per share on the company’s 4.75% non-cumulative preferred stock, Series F, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.296875 per depositary share (NYSE: MET PRF).
    • Semi-annual dividend of $19.250 per share on the company’s 3.850% fixed rate reset non-cumulative preferred stock, Series G, with a liquidation preference of $1,000 per share.
    • Quarterly dividend of $0.25000000 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA), subject to the final confirmation that the company has met the financial tests specified in the certificate of designations for the Series A preferred stock, which the company anticipates will be made and announced on or about March 5,2021. The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock, and will set an ex-dividend date after the confirmatory announcement.

    The above dividends will be payable March 15, 2021, to shareholders of record as of Friday, February 26, 2021, due to the record date occurring on Sunday, February 28, 2021.

    About MetLife

    MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

    Forward-Looking Statements

    The forward-looking statements in this news release, such as “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it has no obligation to correct or update any of these statements.

    Get the next $PRE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRE
    $MET
    $PRA

    CompanyDatePrice TargetRatingAnalyst
    MetLife Inc.
    $MET
    9/19/2025$84.00Overweight → Neutral
    Piper Sandler
    MetLife Inc.
    $MET
    9/16/2025$95.00Outperform
    Wolfe Research
    ProAssurance Corporation
    $PRA
    4/10/2025Mkt Perform → Underperform
    Raymond James
    ProAssurance Corporation
    $PRA
    4/3/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    MetLife Inc.
    $MET
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    ProAssurance Corporation
    $PRA
    11/11/2024$18.00Overweight → Neutral
    Piper Sandler
    MetLife Inc.
    $MET
    10/9/2024$97.00Buy
    TD Cowen
    MetLife Inc.
    $MET
    9/5/2024$91.00Overweight
    Barclays
    More analyst ratings

    $PRE
    $MET
    $PRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Prenetics Global Limited Announces Proposed Public Offering

    CHARLOTTE, N.C., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited ("Prenetics" or the "Company"), a leading health sciences company, today announced that it has commenced a public offering of shares of its Class A Ordinary Shares (or prefunded warrants in lieu thereof) and common warrants (the "Offering"). The Company will allocate proceeds from the offering toward the global expansion of IM8, driven by its explosive growth, and the strategic accumulation of Bitcoin (BTC) as part of its pioneering dual-pronged health and wealth strategy. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the a

    10/24/25 8:30:00 PM ET
    $PRE
    Blank Checks
    Finance

    Empathy Launches Leave Support Solution with MetLife

    Expanded collaboration to bring innovation and reimagine leave experience for millions of employees Empathy, a leading technology company transforming how the world plans for and manages life's toughest moments, and MetLife, a trusted provider of disability and leave management services, are joining forces to launch Leave Support, an innovative digital platform designed to guide employees through the range of emotional and practical challenges of taking a leave of absence from work. According to the U.S. Bureau of Labor Statistics, roughly 2.6 million employees take a leave of absence from work any given week due to illness or injury. Navigating the complexities of leave, from filing cl

    10/15/25 11:00:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife's Triangle Tech X Showcases the Latest on STEM Innovations

    Free virtual sessions connect tech experts with global audience MetLife's Triangle Tech X (TTX) conference returns for its seventh year on October 28-29, connecting a global audience with experts focused on innovations in STEM (Science, Technology, Engineering, Mathematics). The free, virtual conference will explore how STEM organizations and people can thrive, adapt and foster trust in the digital age, while unlocking the growth potential of emerging technologies such as Artificial Intelligence. Register today to join live or view replays Register now to access the conference replays and watch when your schedule allows. Visit here for more details including the full agenda, speaker l

    10/14/25 11:51:00 PM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hay Laura J was granted 534 units of Common Stock, increasing direct ownership by 14% to 4,261 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    10/3/25 4:03:05 PM ET
    $MET
    Life Insurance
    Finance

    Director Harris Carla A was granted 534 shares, increasing direct ownership by 6% to 9,048 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    10/3/25 4:03:10 PM ET
    $MET
    Life Insurance
    Finance

    Director Mckenzie Diana was granted 534 shares, increasing direct ownership by 2% to 22,757 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    10/3/25 4:02:59 PM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    SEC Filings

    View All

    Amendment: SEC Form 6-K/A filed by Prenetics Global Limited

    6-K/A - Prenetics Global Ltd (0001876431) (Filer)

    10/21/25 8:32:13 AM ET
    $PRE
    Blank Checks
    Finance

    MetLife Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - METLIFE INC (0001099219) (Filer)

    10/14/25 4:14:36 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - METLIFE INC (0001099219) (Filer)

    9/22/25 8:01:55 AM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MetLife downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded MetLife from Overweight to Neutral and set a new price target of $84.00

    9/19/25 8:25:43 AM ET
    $MET
    Life Insurance
    Finance

    Wolfe Research initiated coverage on MetLife with a new price target

    Wolfe Research initiated coverage of MetLife with a rating of Outperform and set a new price target of $95.00

    9/16/25 8:09:09 AM ET
    $MET
    Life Insurance
    Finance

    ProAssurance downgraded by Raymond James

    Raymond James downgraded ProAssurance from Mkt Perform to Underperform

    4/10/25 8:50:33 AM ET
    $PRA
    Property-Casualty Insurers
    Finance

    $PRE
    $MET
    $PRA
    Leadership Updates

    Live Leadership Updates

    View All

    MetLife and Global Citizen Announce Major Partnership to Drive Economic Change and Foster Resilient Communities

    MetLife Foundation Commits $9 Million to FIFA Global Citizen Education Fund Today at the 2025 Global Citizen Festival, MetLife, a leading financial services company providing insurance and employee benefits, proudly announced becoming a major partner with Global Citizen, the world's largest movement to end extreme poverty, with a new three-year partnership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250926660696/en/NEW YORK, NEW YORK - SEPTEMBER 27: (L-R) Michael Roberts and Nuria Garcia speak onstage during the 2025 Global Citizen Festival at Central Park on September 27, 2025 in New York City. (Photo by Noam Galai/Getty

    9/27/25 9:15:00 PM ET
    $MET
    Life Insurance
    Finance

    Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

    -  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation -  Following strategic divestiture, Prenetics leverages strengthened $117M balance sheet to execute comprehensive Bitcoin strategy with board-approved majority allocation, institutional financing partnerships, and alpha-generating initiatives. CHARLOTTE, N.C., June 18, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE), a leading health sciences company, today announced it has become the first healthcare company to establish a Bitcoin treasury, completing a $20 million Bitcoin purchase of 187.42 BTC at an averag

    6/18/25 8:45:00 AM ET
    $PRE
    Blank Checks
    Finance

    MetLife Investment Management Agrees to Acquire Traditional Fixed Income and Equity Portfolio Management Teams Managing $6 Billion From Mesirow

    Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi

    1/8/25 8:30:00 AM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    Financials

    Live finance-specific insights

    View All

    MetLife to Hold Conference Call for Third Quarter 2025 Results

    MetLife, Inc. (NYSE:MET) today announced that it will hold its third quarter 2025 earnings conference call and audio webcast on Thursday, November 6, 2025, from 9-10 a.m. (ET). The call will follow MetLife's issuance of its third quarter 2025 earnings news release and Third Quarter 2025 Financial Supplement on Wednesday, November 5, 2025, after the market closes. The news release and Third Quarter 2025 Financial Supplement will also be available on the MetLife Investor Relations webpage (https://investor.metlife.com). The conference call will be available live via the internet. To listen to the conference call, click the following link to register (https://events.q4inc.com/attendee/817838

    10/8/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Declares Fourth Quarter 2025 Common Stock Dividend

    MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a fourth quarter 2025 common stock dividend of $0.5675 per share. The dividend will be payable on Dec. 9, 2025, to shareholders of record as of Nov. 4, 2025. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe an

    10/7/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces Full Redemption of Series G Preferred Stock

    Full Redemption of 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G MetLife, Inc. (NYSE:MET) today announced that it will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, liquidation preference of $1,000 per share ("Series G Preferred Stock"), at a redemption price of $1,000 per share of Series G Preferred Stock. All outstanding shares of Series G Preferred Stock will be redeemed on the dividend payment date of September 15, 2025. Regular dividends on the outstanding shares of Series G Preferred Stock of $19.250 per share will be paid separately on September 15, 2025, to holders of record as of the close of business o

    9/2/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ProAssurance Corporation

    SC 13G/A - PROASSURANCE CORP (0001127703) (Subject)

    11/14/24 1:28:29 PM ET
    $PRA
    Property-Casualty Insurers
    Finance

    Amendment: SEC Form SC 13G/A filed by Prenetics Global Limited

    SC 13G/A - Prenetics Global Ltd (0001876431) (Subject)

    11/14/24 12:30:15 PM ET
    $PRE
    Blank Checks
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance